How I Elevated My Wortmannin Accomplishments By 150%

The patient characteristics in the database have been shown to be broadly representative of all South Australian prostate cancer diagnoses [21]. Data are collected independently of clinicians using electronic pathology databases and clinical case note reviews [21]. We prospectively collected data on 1376 men diagnosed with prostate cancer and treated with RP. Where clinical stage could not be decided a missing value was assigned. Biochemical recurrence (BCR) was defined as a single PSA >0.2?ng/mL or a value of 0.2?ng/mL given a subsequent increase over 0.2?ng/mL. Secondary therapy following RP was deemed a recurrence if prescribed due to a rising PSA. Patients receiving secondary therapy with no rising PSA following RP were excluded from analysis (N= 28). http://www.selleckchem.com/products/CHIR-99021.html Follow-up was measured until BCR, death or the most recent PSA value. The 1992 American Joint Committee on Cancer TNM classification was used for assignment of clinical stage. Predictions of BCRFP were generated using the nomogram equations by one of the authors (CY). The predicted probabilities of BCR for the CAPRA score were taken as quoted in the derivation paper [6]. For the CAPRA score, patients with a baseline PSA value http://www.selleck.cn/products/wortmannin.html scored zero for their PSA component, as has been done in a previous validation [12]. The performance of the risk assessment tools was measured by comparing the concordance (calculated using Harrell's C index) and calibration of the tools. Harrell's C index is similar to the area under the curve statistic for receiver�Coperating characteristic plots but allows calculation of concordance in continuous and censored data (such as time to event data). Harrell's C measures the concordance between the predicted failure order of a pair of subjects and the observed order. Because 95% confidence intervals for Harrell's C statistic cannot be used to gauge whether one tool outperforms another, a test of the difference of Harrell's C between pairs of risk assessment tools was performed, as described by Newson [22], using the lincom command in STATA. While concordance is a measure of how well a tool can http://www.selleckchem.com/products/LY294002.html determine the relative risk of individual patients (compared with each other) in the population sample, calibration reflects how well the tool predicts an absolute outcome, such as the likelihood of recurrence at 3 years. Kaplan�CMeier analysis was used to determine the actuarial 3-year BCRFP and this was plotted against predicted BCRFP to visually assess the calibration of the tools. Patients were either grouped by the seven CAPRA categories or split into quintiles ordered by predicted risk for each of the nomograms.